vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($821.5M vs $766.5M, roughly 1.1× SCANSOURCE, INC.). SCANSOURCE, INC. runs the higher net margin — 2.2% vs -143.3%, a 145.5% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (6.1% vs 2.5%). SCANSOURCE, INC. produced more free cash flow last quarter ($28.9M vs $-179.5M). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (3.4% CAGR vs 0.9%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
ACHC vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $821.5M | $766.5M |
| Net Profit | $-1.2B | $16.5M |
| Gross Margin | — | 13.4% |
| Operating Margin | -142.4% | 2.3% |
| Net Margin | -143.3% | 2.2% |
| Revenue YoY | 6.1% | 2.5% |
| Net Profit YoY | -3710.4% | -3.3% |
| EPS (diluted) | $-12.98 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $821.5M | $766.5M | ||
| Q3 25 | $851.6M | $739.6M | ||
| Q2 25 | $869.2M | $812.9M | ||
| Q1 25 | $770.5M | $704.8M | ||
| Q4 24 | $774.2M | $747.5M | ||
| Q3 24 | $815.6M | $775.6M | ||
| Q2 24 | $796.0M | $746.1M | ||
| Q1 24 | $768.1M | $752.6M |
| Q4 25 | $-1.2B | $16.5M | ||
| Q3 25 | $36.2M | $19.9M | ||
| Q2 25 | $30.1M | $20.1M | ||
| Q1 25 | $8.4M | $17.4M | ||
| Q4 24 | $32.6M | $17.1M | ||
| Q3 24 | $68.1M | $17.0M | ||
| Q2 24 | $78.5M | $16.1M | ||
| Q1 24 | $76.4M | $12.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | -142.4% | 2.3% | ||
| Q3 25 | 4.7% | 3.5% | ||
| Q2 25 | 5.8% | 3.3% | ||
| Q1 25 | 1.7% | 3.2% | ||
| Q4 24 | 4.9% | 2.5% | ||
| Q3 24 | 12.1% | 2.3% | ||
| Q2 24 | 13.4% | 2.9% | ||
| Q1 24 | 12.9% | 2.3% |
| Q4 25 | -143.3% | 2.2% | ||
| Q3 25 | 4.3% | 2.7% | ||
| Q2 25 | 3.5% | 2.5% | ||
| Q1 25 | 1.1% | 2.5% | ||
| Q4 24 | 4.2% | 2.3% | ||
| Q3 24 | 8.4% | 2.2% | ||
| Q2 24 | 9.9% | 2.2% | ||
| Q1 24 | 9.9% | 1.7% |
| Q4 25 | $-12.98 | $0.75 | ||
| Q3 25 | $0.40 | $0.89 | ||
| Q2 25 | $0.33 | $0.87 | ||
| Q1 25 | $0.09 | $0.74 | ||
| Q4 24 | $0.36 | $0.70 | ||
| Q3 24 | $0.74 | $0.69 | ||
| Q2 24 | $0.85 | $0.66 | ||
| Q1 24 | $0.83 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.2M | $83.5M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $1.9B | $910.9M |
| Total Assets | $5.5B | $1.7B |
| Debt / EquityLower = less leverage | 1.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.2M | $83.5M | ||
| Q3 25 | $118.7M | $124.9M | ||
| Q2 25 | $131.4M | $126.2M | ||
| Q1 25 | $91.2M | $146.3M | ||
| Q4 24 | $76.3M | $110.5M | ||
| Q3 24 | $82.1M | $145.0M | ||
| Q2 24 | $77.2M | $185.5M | ||
| Q1 24 | $77.3M | $159.1M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $1.9B | $910.9M | ||
| Q3 25 | $3.1B | $914.0M | ||
| Q2 25 | $3.1B | $906.4M | ||
| Q1 25 | $3.0B | $901.7M | ||
| Q4 24 | $3.1B | $900.7M | ||
| Q3 24 | $3.0B | $920.9M | ||
| Q2 24 | $3.0B | $924.3M | ||
| Q1 24 | $2.9B | $944.1M |
| Q4 25 | $5.5B | $1.7B | ||
| Q3 25 | $6.4B | $1.7B | ||
| Q2 25 | $6.3B | $1.8B | ||
| Q1 25 | $6.1B | $1.7B | ||
| Q4 24 | $6.0B | $1.7B | ||
| Q3 24 | $5.9B | $1.8B | ||
| Q2 24 | $5.7B | $1.8B | ||
| Q1 24 | $5.5B | $1.8B |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-86.3M | $30.8M |
| Free Cash FlowOCF − Capex | $-179.5M | $28.9M |
| FCF MarginFCF / Revenue | -21.8% | 3.8% |
| Capex IntensityCapex / Revenue | 11.3% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | $-439.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-86.3M | $30.8M | ||
| Q3 25 | $73.2M | $23.2M | ||
| Q2 25 | $133.5M | — | ||
| Q1 25 | $11.5M | $66.1M | ||
| Q4 24 | $116.7M | $-6.2M | ||
| Q3 24 | $163.1M | $44.8M | ||
| Q2 24 | $171.1M | — | ||
| Q1 24 | $-321.3M | $160.2M |
| Q4 25 | $-179.5M | $28.9M | ||
| Q3 25 | $-63.0M | $20.8M | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | $64.6M | ||
| Q4 24 | $-86.8M | $-8.2M | ||
| Q3 24 | $-27.1M | $42.5M | ||
| Q2 24 | $16.9M | — | ||
| Q1 24 | $-463.7M | $157.7M |
| Q4 25 | -21.8% | 3.8% | ||
| Q3 25 | -7.4% | 2.8% | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | 9.2% | ||
| Q4 24 | -11.2% | -1.1% | ||
| Q3 24 | -3.3% | 5.5% | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -60.4% | 21.0% |
| Q4 25 | 11.3% | 0.3% | ||
| Q3 25 | 16.0% | 0.3% | ||
| Q2 25 | 19.3% | 0.3% | ||
| Q1 25 | 22.7% | 0.2% | ||
| Q4 24 | 26.3% | 0.3% | ||
| Q3 24 | 23.3% | 0.3% | ||
| Q2 24 | 19.4% | 0.2% | ||
| Q1 24 | 18.5% | 0.3% |
| Q4 25 | — | 1.87× | ||
| Q3 25 | 2.02× | 1.17× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | 3.79× | ||
| Q4 24 | 3.58× | -0.36× | ||
| Q3 24 | 2.39× | 2.64× | ||
| Q2 24 | 2.18× | — | ||
| Q1 24 | -4.21× | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
